证券代码：605008 证券简称：长鸿高科 公告编号：2025-048 宁波长鸿高分子科技股份有限公司 关于发行股份、可转换公司债券及支付现金购买资产并募集 配套资金暨关联交易事项的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次交易的基本情况 宁波长鸿高分子科技股份有限公司（以下简称"公司"）拟通过发行股份、 可转换公司债券及支付现金的方式购买广西长科新材料有限公司 100%股权并向 不超过 35 名特定投资者发行股份募集配套资金（以下简称"本次交易"）。根 据《上市公司重大资产重组管理办法》《上海证券交易所股票上市规则》等相关 规定，经初步测算，本次交易预计构成重大资产重组且构成关联交易；本次交易 不会导致公司控股股东及实际控制人发生变更，不构成重组上市。 二、本次交易进展情况 划重大资产重组的停牌公告》（公告编号：2025-037）。经向上海证券交易所申 请，公司股票于 2025 年 7 月 8 日开市起停牌。停牌期间，公司按照相关规定披 露了《宁波长鸿高分子科技股份有限公司关于筹划重大资产重组的停牌进 ...

证券代码：605008 证券简称：长鸿高科 公告编号：2025-049 公司于 2023 年 6 月 6 日在上海证券交易所网站披露了《关于涉及诉讼的公 告》（公告编号：2023-042），对原告上海聚友化工有限公司与中科启程新材料 科技（海南）有限公司（第一被告）、扬州惠通科技股份有限公司（第二被告）、 宁波长鸿高分子科技股份有限公司（第三被告）、浙江长鸿生物材料有限公司（第 四被告）就 PBS 与 PBAT"聚酯连续聚合制备工艺"技术秘密纠纷事项进行了信 息披露。 二、诉讼进展 截至本公告披露日，公司收到江苏省高级人民法院民事裁定书（（2023）苏 民初 5 号），原告上海聚友化工有限公司向江苏省高级人民法院提出撤诉申请， 法院认为上海聚友化工有限公司申请撤诉不违反法律规定，准许上海聚友化工有 限公司撤诉。 ? 上市公司所处的当事人地位：宁波长鸿高分子科技股份有限公司（以下简称 "公司"）和子公司浙江长鸿生物材料有限公司分别为第三被告和第四被告； ? 涉案的金额：30,000 万元； ? 是否对上市公司的损益产生负面影响：案件已撤诉，本次诉讼事项对公司本 期利润或期后利润不会产生负面影响。 一、诉讼基本情 ...

2025 年 7 月 8 日，公司披露了《宁波长鸿高分子科技股份有限公司关于筹 划重大资产重组的停牌公告》（公告编号：2025-037）。经向上海证券交易所申 请，公司股票于 2025 年 7 月 8 日开市起停牌。停牌期间，公司按照相关规定披 露了《宁波长鸿高分子科技股份有限公司关于筹划重大资产重组的停牌进展公 告》（公告编号：2025-040）。 一、本次交易的基本情况 宁波长鸿高分子科技股份有限公司（以下简称"公司"）拟通过发行股份、 可转换公司债券及支付现金的方式购买广西长科新材料有限公司 100%股权并向 不超过 35 名特定投资者发行股份募集配套资金（以下简称"本次交易"）。根 据《上市公司重大资产重组管理办法》《上海证券交易所股票上市规则》等相关 规定，经初步测算，本次交易预计构成重大资产重组且构成关联交易；本次交易 不会导致公司控股股东及实际控制人发生变更，不构成重组上市。 二、本次交易进展情况 证券代码：605008 证券简称：长鸿高科 公告编号：2025-048 宁波长鸿高分子科技股份有限公司 关于发行股份、可转换公司债券及支付现金购买资产并募集 配套资金暨关联交易事项的进展公告 本公司董 ...

关于诉讼进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：605008 证券简称：长鸿高科 公告编号：2025-049 宁波长鸿高分子科技股份有限公司 案件所处的诉讼阶段：原告已撤诉； 上市公司所处的当事人地位：宁波长鸿高分子科技股份有限公司（以下简称 "公司"）和子公司浙江长鸿生物材料有限公司分别为第三被告和第四被告； 涉案的金额：30,000 万元； 是否对上市公司的损益产生负面影响：案件已撤诉，本次诉讼事项对公司本 期利润或期后利润不会产生负面影响。 负担。 三、本次诉讼对公司的影响 案件已撤诉，本次诉讼事项对公司本期利润或期后利润不会产生负面影响。 特此公告。 重要内容提示： 一、诉讼基本情况 公司于 2023 年 6 月 6 日在上海证券交易所网站披露了《关于涉及诉讼的公 告》（公告编号：2023-042），对原告上海聚友化工有限公司与中科启程新材料 科技（海南）有限公司（第一被告）、扬州惠通科技股份有限公司（第二被告）、 宁波长鸿高分子科技股份有限公司（第三被告）、浙江长鸿生物材料有限公司（第 ...

Core Viewpoint - The company plans to acquire 100% equity of Guangxi Changke New Materials Co., Ltd. through a combination of issuing shares, convertible bonds, and cash payments, indicating a significant asset restructuring and related party transaction [1] Group 1: Transaction Details - The transaction is expected to constitute a major asset restructuring and related party transaction, but will not lead to a change in the company's controlling shareholder or actual controller, nor will it constitute a reverse listing [1] - The company's stock will be suspended from trading on July 8, 2025, and a board meeting will be held on July 17 to review the relevant proposals [1] - As of the announcement date, the company and related parties are actively advancing due diligence, auditing, and evaluation related to the transaction [1] Group 2: Funding and Investor Engagement - The company plans to issue shares to no more than 35 specific investors to raise matching funds for the acquisition [1] - The company will fulfill its information disclosure obligations in a timely manner based on the progress of the transaction [1]

长鸿高科最新一期业绩显示，截至2025一季报，公司营业总收入7.18亿元、同比减少6.93%，归属净利 润1642.89万元，同比减少125.46%，扣非净利润2148.42万元，同比减少151.60%，流动比率0.510、速动 比率0.425、资产负债率66.25%。 天眼查商业履历信息显示，宁波长鸿高分子科技股份有限公司，成立于2012年，位于宁波市，是一家以 从事化学原料和化学制品制造业为主的企业。企业注册资本64596.2414万人民币，实缴资本64596.2414 万人民币。公司法定代表人为王正波。 通过天眼查大数据分析，宁波长鸿高分子科技股份有限公司共对外投资了4家企业，参与招投标项目43 次，知识产权方面有商标信息6条，专利信息23条，此外企业还拥有行政许可33个。 来源：金融界 金融界消息 截至2025年8月15日收盘，长鸿高科（605008）报收于14.25元，上涨3.41%，换手率0.7%， 成交量4.49万手，成交金额6373.02万元。 资金流向方面，今日主力资金净流入1033.60万元，占比成交额16.22%。其中，超大单净流入1207.74万 元、占成交额18.95%，大单净流出1 ...

金融界消息 截至2025年8月12日收盘，长鸿高科（605008）报收于14.1元，下跌1.54%，换手率0.45%， 成交量2.86万手，成交金额4040.03万元。 资金流向方面，今日主力资金净流出1109.60万元，占比成交额27.47%。其中，超大单净流出1031.52万 元、占成交额25.53%，大单净流出78.08万元、占成交额1.93%，中单净流出流入529.59万元、占成交额 13.11%，小单净流入580.01万元、占成交额14.36%。 天眼查商业履历信息显示，宁波长鸿高分子科技股份有限公司，成立于2012年，位于宁波市，是一家以 从事化学原料和化学制品制造业为主的企业。企业注册资本64596.2414万人民币，实缴资本64596.2414 万人民币。公司法定代表人为王正波。 通过天眼查大数据分析，宁波长鸿高分子科技股份有限公司共对外投资了4家企业，参与招投标项目43 次，知识产权方面有商标信息6条，专利信息23条，此外企业还拥有行政许可33个。 来源：金融界 长鸿高科最新一期业绩显示，截至2025一季报，公司营业总收入7.18亿元、同比减少6.93%，归属净利 润1642.89万元，同比 ...

Core Viewpoint - Changhong Gaoke (605008.SH) has revised its forecast for the first half of 2025, expecting a significant decrease in net profit compared to the previous year, indicating potential financial distress for the company [1][2]. Financial Performance Summary - The company anticipates a net profit attributable to shareholders of between 1.4 million to 2 million yuan for the first half of 2025, a decrease of 94.57 million to 95.17 million yuan, representing a year-on-year decline of 97.93% to 98.55% [1]. - The expected net profit after deducting non-recurring gains and losses is projected to be between -6 million to -5 million yuan, a decrease of 75.66 million to 76.66 million yuan, reflecting a year-on-year decline of 107.08% to 108.49% [1]. - In the first half of 2024, the company reported a net profit of 96.57 million yuan and a net profit of 70.66 million yuan after deducting non-recurring gains and losses [2]. Transaction and Fundraising Summary - On July 18, 2025, the company announced a plan to acquire 100% equity of Guangxi Changke through issuing shares, convertible bonds, and cash, while also raising matching funds from no more than 35 specific investors [2][4]. - The final transaction price for the acquisition will be determined based on an asset evaluation report from a qualified institution, and the specific use of raised funds will be disclosed in the restructuring report [3][4]. - The controlling shareholder of Guangxi Changke is Tao Chunfeng, who holds 100% of the equity through three entities, making this transaction an affiliated transaction under relevant regulations [4]. Historical Financial Data - Guangxi Changke's revenue for the years 2023, 2024, and the first half of 2025 were 667.80 million yuan, 1.0173 billion yuan, and 807.90 million yuan, respectively, with net profits of -33.60 million yuan, -79.08 million yuan, and 34.91 million yuan [5]. - Changhong Gaoke was listed on the Shanghai Stock Exchange on August 21, 2020, with an initial public offering raising a total of 484.84 million yuan [5].

[Performance Forecast Correction Details](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The company further lowered its 2025 semi-annual performance forecast, showing expanded year-on-year declines in key profitability metrics [Performance Forecast Period](index=1&type=section&id=%EF%BC%88%E4%B8%80%EF%BC%89%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%9C%9F%E9%97%B4) This performance forecast covers financial data for the period from January 1 to June 30, 2025 - The performance forecast covers the first half of 2025[1](index=1&type=chunk) [Previous Performance Forecast](index=1&type=section&id=%EF%BC%88%E4%BA%8C%EF%BC%89%E5%89%8D%E6%AC%A1%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) The preliminary forecast on July 15, 2025, indicated a substantial year-on-year decline in H1 2025 net profit attributable to shareholders - The previous forecast already indicated a significant decline in H1 2025 performance, with **net profit attributable to shareholders expected to decrease by over 93% year-on-year**[2](index=2&type=chunk) [Corrected Performance Forecast](index=1&type=section&id=%EF%BC%88%E4%B8%89%EF%BC%89%E6%9B%B4%E6%AD%A3%E5%90%8E%E7%9A%84%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%83%85%E5%86%B5) Corrected data reveals a further decline in H1 2025 performance, with expanded year-on-year decreases in key profitability metrics - The corrected net profit attributable to shareholders is expected to decline by up to **98.55% year-on-year**, with **non-recurring net loss doubling** compared to the previous forecast[3](index=3&type=chunk) 2025 Semi-Annual Performance Forecast Correction Comparison | Indicator | Previous Forecast (RMB) | Corrected Forecast (RMB) | Year-on-Year Change (Corrected) | | :--- | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | 4,000,000 to 6,000,000 | 1,400,000 to 2,000,000 | -97.93% to -98.55% | | **Net Profit Attributable to Shareholders Excluding Non-recurring Items** | -3,000,000 to -1,500,000 | -6,000,000 to -5,000,000 | -107.08% to -108.49% | [Performance Comparison Baseline (2024 Same Period)](index=2&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8A%E5%B9%B4%E5%90%8C%E6%9C%9F%E4%B8%9A%E7%BB%A9%E6%83%85%E5%86%B5) The announcement provides key financial data for H1 2024 as a performance comparison baseline, contextualizing the significant year-on-year decline 2024 Semi-Annual Performance Review | Indicator | Amount (RMB) | | :--- | :--- | | Net Profit Attributable to Shareholders | 96,570,900 | | Net Profit Attributable to Shareholders Excluding Non-recurring Items | 70,656,500 | | Basic Earnings Per Share | 0.15 | [Analysis of Performance Forecast Correction Reasons](index=2&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A%E6%9B%B4%E6%AD%A3%E7%9A%84%E4%B8%BB%E8%A6%81%E5%8E%9F%E5%9B%A0) The company attributes the correction to in-depth financial accounting, where minor absolute deviations were amplified by the extremely small net profit base - The primary reason for the performance correction is minor data discrepancies found during in-depth financial accounting, which were amplified into large percentage changes due to the **small net profit base**[5](index=5&type=chunk) [Risk Warning](index=2&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company explicitly states the corrected performance forecast data is preliminary and unaudited, subject to change, with no other significant uncertainties - The performance forecast data is **unaudited and preliminary**, with final figures subject to the audited semi-annual report[6](index=6&type=chunk) [Other Explanations](index=2&type=section&id=%E4%BA%94%E3%80%81%E5%85%B6%E4%BB%96%E8%AF%B4%E6%98%8E%E4%BA%8B%E9%A1%B9) The company reiterates that final accurate financial data will be released in the official 2025 semi-annual report, advises investors of risks, and apologizes for the inconvenience - The company's board of directors apologizes for the performance forecast correction and advises investors to refer to the **final 2025 semi-annual report**[7](index=7&type=chunk)

Group 1 - The core viewpoint of the article highlights the active M&A restructuring in the A-share market, with significant developments in state-owned enterprise mergers and innovative restructuring cases emerging [2][5][6] - China Shipbuilding Industry Corporation (China Shipbuilding) and China State Shipbuilding Corporation (China State Shipbuilding) have received approval from the China Securities Regulatory Commission (CSRC) for a share swap merger, with the transaction amounting to 115.15 billion yuan [6][7] - The merger will enhance the operational quality and core competitiveness of the listed company, while also addressing issues of industry competition and protecting minority shareholders' rights [7][9] Group 2 - The "M&A Six Guidelines" have stimulated the market, leading to over 2,400 listed companies disclosing M&A restructuring announcements since its release [5][10] - The recent M&A activities include China Shenhua's acquisition of assets from the State Energy Group, involving coal and related assets from over 13 companies, indicating a trend towards large-scale transactions [8][10] - The payment methods for M&A transactions have diversified, with companies utilizing various financial instruments such as convertible bonds and M&A loans to facilitate deals [10][12] Group 3 - The restructuring activities are primarily driven by state-owned enterprise reforms, industrial upgrades, and asset securitization, with a focus on integrating resources and enhancing market competitiveness [6][13] - Investment institutions and brokerage firms are actively participating in the M&A market, adjusting their strategies to focus on M&A business and enhancing their service capabilities [13][14] - Future M&A activities are expected to emphasize industrial integration and transformation, with companies adopting a more cautious approach towards restructuring [15]